Core Laboratories Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: To re-elect two current Class I Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2029 and until their successors shall have been duly elected and qualified: Curtis Anastasio

Core Laboratories Inc.’s own tally for this item (“Elect Director: Curtis Anastasio”): 39,271,486 for, 364,916 withheld, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 70 asset managers below reported 20,365,521 for, 29,250 withheld, 2 abstained.

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

Description as filed by funds: To re-elect two current Class I Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2029 and until their successors shall have been duly elected and qualified: Harvey Klingensmith

Core Laboratories Inc.’s own tally for this item (“Elect Director: Harvey Klingensmith”): 35,880,017 for, 3,756,385 withheld, per its Form 8-K filed May 13, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 70 asset managers below reported 20,086,818 for, 307,931 withheld, 24 abstained.

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

Description as filed by funds: To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis ("CD&A"), and the compensation of the Company's named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission's compensation disclosure rules, including the compensation tables.

Core Laboratories Inc.’s own tally for this item (“3. Approving the Compensation of the Company's Named Executive Officers: An advisory vote on the compensation of the Company's named executive officers”): 38,265,683 for, 1,263,224 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Approving the Compensation of the Company's Named Executive Officers : An advisory vote on the compensation of the Company's named executive officers was approved as follows:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 69 managers: 19,942,521 for, 452,134 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 198 managers: 21,180,641 for, 670,777 against, 36,142 abstained, 160,528 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of KPMG LLP as the Company's independent registered public accountants for the year ending December 31, 2026; and

Core Laboratories Inc.’s own tally for this item (“2. Appointment of KPMG as Independent Registered Public Accountant: The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, 2026”): 41,220,974 for, 484,159 against — passed, per its Form 8-K filed May 13, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Appointment of KPMG as Independent Registered Public Accountant : The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, 2026 was approved as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Core Laboratories Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify KPMG LLP as Auditors” (2 managers, 49,186 for).

The 68 asset managers below reported 20,321,562 for, 24,025 against.

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.